Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063180) titled 'Nationwide Analysis of Radioligand Therapy Implementation in Japan: Trends and Barriers Using Claims Data and Questionnaire Survey' on Oct. 5.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - National Cancer Center
Condition:
Condition - 1) Patients who received treatment with a radiopharmaceutical therapy agent listed on the National Health Insurance (NHI) drug price list in Japan.
Although [(131)I]I is approved in Japan for hyperthyroidism as well as thyroid cancer, this study will include only patients who received [(131)I]I for thyroid cancer.
2) Patients who initiated systemic therapy for a n...